Taking the question as asked, rather than the general version of it. They are two different exemptions from the same federal requirements and they buy different things. A 503A pharmacy is regulated primarily by the state board, needs a patient-specific prescription, is exempt from CGMP, and may use a bulk substance that has a USP monograph, is a component of an approved drug, or appears on the 503A bulks list — three independent doorways. A 503B outsourcing facility registers with the FDA, is inspected on a risk basis, must comply with CGMP, may compound for office stock without a patient-specific prescription, and has one doorway to a permitted bulk substance: the 503B bulks list, or the drug shortage list.
I froze a spare vial thinking I was being careful and later found out that is the one thing you are not supposed to do.
The narrow version of the question is what a temperature excursion actually does, and what distinguishes an unopened vial from one already in use.
If the honest answer is that nobody knows, that is a useful answer and I would rather have it.
BethLabQueen said:They are two different exemptions from the same federal requirements and they buy different things.
No disagreement with BethLabQueen. One condition attached. Freezing is the one to avoid, and freeze-thaw more so. Ice-crystal formation and the concentration changes at the phase boundary drive aggregation, and aggregated peptide does not recover on thawing. A vial that has been frozen and thawed is not rescued by returning it to the fridge.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsLeilaHI said:I froze a spare vial thinking I was being careful and later found out that is the one thing you are not supposed to do.
Same position here, arrived at the long way round. Worth adding the genuine exception, because it is real and narrow: a change made for an identified patient where the prescriber determines it produces a significant clinical difference for that patient. A grid of fixed doses offered to everybody is not that, whatever the intake form says.
Clinical perspective, offered as context rather than as advice.
Cold chain shipping for storage and cold: my last order arrived with the cold pack completely melted and the vial at room temperature. I contacted the vendor and they reshipped with better insulation.
What to look for in shipping: styrofoam inner container with ice packs. If your peptide arrives warm, contact the vendor immediately. Don't assume it's still good.